Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Contineum Therapeutics, Inc.
Market Cap
$475.91M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$472.23M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$471.65M
Net Profit Margin
2.94%
TTM Avg
-53.14%
3Y Avg
-197.29%
5Y Avg
-267.69%
Market Cap
$471.57M
Net Profit Margin
-3.06%
TTM Avg
-9.59%
3Y Avg
-17.39%
5Y Avg
-29.37%
Market Cap
$469.12M
Net Profit Margin
-38.37%
TTM Avg
-56.73%
3Y Avg
-82.08%
5Y Avg
-57.25%
Market Cap
$483.54M
Net Profit Margin
11.55%
TTM Avg
13.38%
3Y Avg
8.98%
5Y Avg
-0.37%
Market Cap
$486.01M
Net Profit Margin
-10.85%
TTM Avg
-18.16%
3Y Avg
-29.23%
5Y Avg
-75.36%
Market Cap
$465.75M
Net Profit Margin
-35.69%
TTM Avg
-57.08%
3Y Avg
-75.90%
5Y Avg
-92.95%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | $475.91M | 0.00% | 0.00% | 0.00% | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Arvinas, Inc. (ARVN)vs › | $471.65M | 2.94% | -53.14% | -197.29% | -267.69% |
| Cerus Corporation (CERS)vs › | $471.57M | -3.06% | -9.59% | -17.39% | -29.37% |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | -38.37% | -56.73% | -82.08% | -57.25% |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 11.55% | 13.38% | 8.98% | -0.37% |
| Kamada Ltd. (KMDA)vs › | $467.90M | 11.60% | 10.09% | 6.05% | 5.82% |
| Evolus, Inc. (EOLS)vs › | $486.01M | -10.85% | -18.16% | -29.23% | -75.36% |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | -35.69% | -57.08% | -75.90% | -92.95% |
| Oculis Holding AG (OCS)vs › | $498.52M | -32724.20% | -6251.97% | -3125.99% | -2083.99% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 83.13% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
